From professional translators, enterprises, web pages and freely available translation repositories.
pcav: predpokladaná cav
pcav: predicted cav
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
narcissus humilis (cav.)
narcissus humilis (cav.)
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
rozsah cav (ng/ml)
cav range (ng/ml)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sideritis serrata cav. ex lag.
sideritis serrata cav. ex lag.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
sideritis incana subsp. glauca (cav.)
sideritis incana subsp. glauca (cav.)
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
3 týždne po prvej vakcinácii pre cdv, cav, cpv,
3 weeks after the first vaccination for cdv, cav, cpv,
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
trvanie imunity pre cav-2 nebolo stanovené na základe čelenžnej štúdie.
the duration of immunity against cav-2 was not established by challenge.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kvartilové analýzy cav u pacientov v pivotných štúdiách s posakonazolom vo forme tabliet a perorálnej suspenzie
cav quartile analyses of pivotal patient studies with posaconazole tablet and oral suspension
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
stredná doba prežívania bola 25,0 týždňov u topotekánu a 24,7 týždňov u skupiny cav.
median survivals for the two groups were 25.0 and 24.7 weeks respectively.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
bolo však dokázané, že 3 roky po vakcinácii sú protilátky proti cav-2 stále prítomné.
it was shown that 3 years after the vaccination cav-2 antibodies are still present.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
priemerná predpokladaná cav v rovnovážnom stave, ktorú dosiahli pacienti, bola 1 970 ng/ml.
subjects achieved a mean predicted cav at steady state of 1,970 ng/ml.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vakcína však preukázala navodenie ochrany proti cdv, cav a cpv za prítomnosti rovnakých alebo vyšších hladín materských protilátok než aké možno očakávať v teréne.
however, the vaccine has been proven to be protective against virulent challenge in the presence of maternally derived antibodies to cdv, cav and cpv at levels equal or higher to those likely to be encountered under field conditions.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
osoby, ktoré dostávali 300 mg jedenkrát denne, dosiahli priemernú cav v rovnovážnom stave 1 500 ng/ml.
subjects who received 300 mg once daily achieved a mean cav at steady state of 1500 ng/ml.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podobne v štúdiách profylaxie bola priemerná koncentrácia (average concentration, cav) posakonazolu v rovnovážnom stave u desiatich dospievajúcich (vo veku 13 – 17 rokov) porovnateľná s cav dosiahnutou u dospelých (≥ 18 rokov).
similarly, in the prophylaxis studies, the mean steady-state posaconazole average concentration (cav) was comparable among ten adolescents (13-17 years of age) to cav achieved in adults (≥ 18 years of age).
Last Update: 2017-04-26
Usage Frequency: 3
Quality: